AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria

A. Amoroso, D. Pirulli, F. Florian, D. Puzzer, M. Boniotto, S. Crovella, S. Zezlina, A. Spanò, G. Mazzola, S. Savoldi, C. Ferrettini, S. Berutti, M. Petrarulo, M. Marangella

Research output: Contribution to journalArticle

Abstract

Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder that is caused by a deficiency of alanine: glyoxylate aminotransferase (AGT), which is encoded by a single copy gene (AGXT). Molecular diagnosis was used in conjunction with clinical, biochemical, and enzymological data to evaluate genotype-phenotype correlation. Twenty-three unrelated, Italian PH1 patients were studied, 20 of which were grouped according to severe form of PH1 (group A), adult form (group B), and mild to moderate decrease in renal function (group C). All 23 patients were analyzed by using the single-strand conformation polymorphism technique followed by the sequencing of the 11 AGXT exons. Relevant chemistries, including plasma, urine and dialyzate oxalate and glycolate assays, liver AGT activity, and pyridoxine responsiveness, were performed. Both mutant alleles were found in 21 out of 23 patients, and 13 different mutations were recognized in exons 1, 2, 4, and 10. Normalized AGT activity was lower in the severe form than in the adult form (P <0.05). Double heterozygous patients presented a lower age at the onset of the disease (P = 0.025), and they were more frequent in group A (75%) than in the group B (14%; P = 0.0406). The T444C mutation was more frequent in the severe form (P <0.05), and the opposite was observed for G630A (P <0.05). G630A mutation homozygotes had a higher AGT residual activity (P = 0.00001). This study confirms the allelic heterogeneity of the AGXT, which could to some extent be responsible for the phenotypic heterogeneity in PH1.

Original languageEnglish
Pages (from-to)2072-2079
Number of pages8
JournalJournal of the American Society of Nephrology
Volume12
Issue number10
Publication statusPublished - 2001

Fingerprint

Mutation
glycolic acid
Genes
Exons
Pyridoxine
Oxalates
Dialysis Solutions
Homozygote
Genetic Association Studies
Age of Onset
Alleles
Primary hyperoxaluria type 1
Urine
Kidney
Liver
Alanine-glyoxylate transaminase

ASJC Scopus subject areas

  • Nephrology

Cite this

Amoroso, A., Pirulli, D., Florian, F., Puzzer, D., Boniotto, M., Crovella, S., ... Marangella, M. (2001). AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. Journal of the American Society of Nephrology, 12(10), 2072-2079.

AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. / Amoroso, A.; Pirulli, D.; Florian, F.; Puzzer, D.; Boniotto, M.; Crovella, S.; Zezlina, S.; Spanò, A.; Mazzola, G.; Savoldi, S.; Ferrettini, C.; Berutti, S.; Petrarulo, M.; Marangella, M.

In: Journal of the American Society of Nephrology, Vol. 12, No. 10, 2001, p. 2072-2079.

Research output: Contribution to journalArticle

Amoroso, A, Pirulli, D, Florian, F, Puzzer, D, Boniotto, M, Crovella, S, Zezlina, S, Spanò, A, Mazzola, G, Savoldi, S, Ferrettini, C, Berutti, S, Petrarulo, M & Marangella, M 2001, 'AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria', Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2072-2079.
Amoroso, A. ; Pirulli, D. ; Florian, F. ; Puzzer, D. ; Boniotto, M. ; Crovella, S. ; Zezlina, S. ; Spanò, A. ; Mazzola, G. ; Savoldi, S. ; Ferrettini, C. ; Berutti, S. ; Petrarulo, M. ; Marangella, M. / AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. In: Journal of the American Society of Nephrology. 2001 ; Vol. 12, No. 10. pp. 2072-2079.
@article{af443dda0ac64274a18e80b4d0ae5b34,
title = "AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria",
abstract = "Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder that is caused by a deficiency of alanine: glyoxylate aminotransferase (AGT), which is encoded by a single copy gene (AGXT). Molecular diagnosis was used in conjunction with clinical, biochemical, and enzymological data to evaluate genotype-phenotype correlation. Twenty-three unrelated, Italian PH1 patients were studied, 20 of which were grouped according to severe form of PH1 (group A), adult form (group B), and mild to moderate decrease in renal function (group C). All 23 patients were analyzed by using the single-strand conformation polymorphism technique followed by the sequencing of the 11 AGXT exons. Relevant chemistries, including plasma, urine and dialyzate oxalate and glycolate assays, liver AGT activity, and pyridoxine responsiveness, were performed. Both mutant alleles were found in 21 out of 23 patients, and 13 different mutations were recognized in exons 1, 2, 4, and 10. Normalized AGT activity was lower in the severe form than in the adult form (P <0.05). Double heterozygous patients presented a lower age at the onset of the disease (P = 0.025), and they were more frequent in group A (75{\%}) than in the group B (14{\%}; P = 0.0406). The T444C mutation was more frequent in the severe form (P <0.05), and the opposite was observed for G630A (P <0.05). G630A mutation homozygotes had a higher AGT residual activity (P = 0.00001). This study confirms the allelic heterogeneity of the AGXT, which could to some extent be responsible for the phenotypic heterogeneity in PH1.",
author = "A. Amoroso and D. Pirulli and F. Florian and D. Puzzer and M. Boniotto and S. Crovella and S. Zezlina and A. Span{\`o} and G. Mazzola and S. Savoldi and C. Ferrettini and S. Berutti and M. Petrarulo and M. Marangella",
year = "2001",
language = "English",
volume = "12",
pages = "2072--2079",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "10",

}

TY - JOUR

T1 - AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria

AU - Amoroso, A.

AU - Pirulli, D.

AU - Florian, F.

AU - Puzzer, D.

AU - Boniotto, M.

AU - Crovella, S.

AU - Zezlina, S.

AU - Spanò, A.

AU - Mazzola, G.

AU - Savoldi, S.

AU - Ferrettini, C.

AU - Berutti, S.

AU - Petrarulo, M.

AU - Marangella, M.

PY - 2001

Y1 - 2001

N2 - Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder that is caused by a deficiency of alanine: glyoxylate aminotransferase (AGT), which is encoded by a single copy gene (AGXT). Molecular diagnosis was used in conjunction with clinical, biochemical, and enzymological data to evaluate genotype-phenotype correlation. Twenty-three unrelated, Italian PH1 patients were studied, 20 of which were grouped according to severe form of PH1 (group A), adult form (group B), and mild to moderate decrease in renal function (group C). All 23 patients were analyzed by using the single-strand conformation polymorphism technique followed by the sequencing of the 11 AGXT exons. Relevant chemistries, including plasma, urine and dialyzate oxalate and glycolate assays, liver AGT activity, and pyridoxine responsiveness, were performed. Both mutant alleles were found in 21 out of 23 patients, and 13 different mutations were recognized in exons 1, 2, 4, and 10. Normalized AGT activity was lower in the severe form than in the adult form (P <0.05). Double heterozygous patients presented a lower age at the onset of the disease (P = 0.025), and they were more frequent in group A (75%) than in the group B (14%; P = 0.0406). The T444C mutation was more frequent in the severe form (P <0.05), and the opposite was observed for G630A (P <0.05). G630A mutation homozygotes had a higher AGT residual activity (P = 0.00001). This study confirms the allelic heterogeneity of the AGXT, which could to some extent be responsible for the phenotypic heterogeneity in PH1.

AB - Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder that is caused by a deficiency of alanine: glyoxylate aminotransferase (AGT), which is encoded by a single copy gene (AGXT). Molecular diagnosis was used in conjunction with clinical, biochemical, and enzymological data to evaluate genotype-phenotype correlation. Twenty-three unrelated, Italian PH1 patients were studied, 20 of which were grouped according to severe form of PH1 (group A), adult form (group B), and mild to moderate decrease in renal function (group C). All 23 patients were analyzed by using the single-strand conformation polymorphism technique followed by the sequencing of the 11 AGXT exons. Relevant chemistries, including plasma, urine and dialyzate oxalate and glycolate assays, liver AGT activity, and pyridoxine responsiveness, were performed. Both mutant alleles were found in 21 out of 23 patients, and 13 different mutations were recognized in exons 1, 2, 4, and 10. Normalized AGT activity was lower in the severe form than in the adult form (P <0.05). Double heterozygous patients presented a lower age at the onset of the disease (P = 0.025), and they were more frequent in group A (75%) than in the group B (14%; P = 0.0406). The T444C mutation was more frequent in the severe form (P <0.05), and the opposite was observed for G630A (P <0.05). G630A mutation homozygotes had a higher AGT residual activity (P = 0.00001). This study confirms the allelic heterogeneity of the AGXT, which could to some extent be responsible for the phenotypic heterogeneity in PH1.

UR - http://www.scopus.com/inward/record.url?scp=0034829759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034829759&partnerID=8YFLogxK

M3 - Article

C2 - 11562405

AN - SCOPUS:0034829759

VL - 12

SP - 2072

EP - 2079

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 10

ER -